These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 338900)

  • 61. [Regulation of enzyme activities involved in pyrimidine synthesis and its application to cancer chemotherapy].
    Shirasaka T; Fujii S
    Gan To Kagaku Ryoho; 1984 Mar; 11(3 Pt 2):760-8. PubMed ID: 6424581
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Potassium oxonate, an enzyme inhibitor compounded in S-1, reduces the suppression of antitumor immunity induced by 5-fluorouracil.
    Yamashita T; Ueda Y; Fuji N; Itoh T; Kurioka H; Shirasaka T; Yamagishi H
    Cancer Chemother Pharmacol; 2006 Aug; 58(2):183-8. PubMed ID: 16317557
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Possible regulation of 5-fluorouracil-induced neuro- and oral toxicities by two biochemical modulators consisting of S-1, a new oral formulation of 5-fluorouracil.
    Kato T; Shimamoto Y; Uchida J; Ohshimo H; Abe M; Shirasaka T; Fukushima M
    Anticancer Res; 2001; 21(3B):1705-12. PubMed ID: 11497250
    [TBL] [Abstract][Full Text] [Related]  

  • 64. [Ftorafur interaction with biopolymers].
    Sharimanov IuG; Liubas B; Vechorkevich T; Dzhandzhaliia MV
    Biofizika; 1984; 29(2):207-11. PubMed ID: 6426528
    [TBL] [Abstract][Full Text] [Related]  

  • 65. 1-(Tetrahydro-2-furanyl)-5-fluorouracil (Ftorafur) determined in rat hair as an index of drug exposure.
    Uematsu T; Miyazawa N; Wada K
    J Pharm Sci; 1993 Dec; 82(12):1272-4. PubMed ID: 8308711
    [TBL] [Abstract][Full Text] [Related]  

  • 66. [Metabolism of 1-(2-tetrahydrofuryl)-5-fluorouracil (FT-207) in human maxillary cancer (OKK) cells in culture].
    Yoneda T; Ogawa T; Sakuda M
    Gan To Kagaku Ryoho; 1985 Jun; 12(6):1306-11. PubMed ID: 3923943
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Studies on antitumor agents. IV. Syntheses and antitumor activities of compounds related to 1-(tetrahydro-2-furanyl)-5-fluorouracil metabolites.
    Ueda S; Takeda S; Yamawaki I; Yamashita J; Yasumoto M; Hashimoto S
    Chem Pharm Bull (Tokyo); 1982 Jan; 30(1):125-31. PubMed ID: 7083401
    [No Abstract]   [Full Text] [Related]  

  • 68. Serum concentrations of 5-FU, ftorafur, and a major serum metabolite following ftorafur chemotherapy.
    Hornbeck CL; Griffiths JC; Floyd RA; Ginther NC; Byfield JE; Sharp TR
    Cancer Treat Rep; 1981; 65(1-2):69-72. PubMed ID: 6784923
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Effect of coadministration of thymine or thymidine on the antitumor activity of 1-(2-tetrahydrofuryl)-5-fluorouracil and 5-fluorouracil.
    Fujii S; Kitano S; Ikenaka K; Fukushima M; Nakamura H; Maehara Y; Shirasaka T
    Gan; 1980 Feb; 71(1):100-6. PubMed ID: 6769735
    [TBL] [Abstract][Full Text] [Related]  

  • 70. [Antitumor activity and function of S-1, a new oral tegafur-based formulation].
    Fukushima M
    Gan To Kagaku Ryoho; 2006 Jun; 33 Suppl 1():19-26. PubMed ID: 16897968
    [TBL] [Abstract][Full Text] [Related]  

  • 71. The therapeutic effects of orally administered 5'-deoxy-5-fluorouridine, 1-(2-tetrahydrofuryl)-5-fluorouracil and 5-fluorouracil on experimental murine tumors.
    Uehara N; Baba H; Nitta K; Kunimoto T; Takeuchi M; Sasaki T; Tanaka T
    Jpn J Cancer Res; 1985 Oct; 76(10):1034-41. PubMed ID: 2934356
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Comparison of 5-fluorouracil and ftorafur. II. Therapeutic response and development of resistance in murine tumors.
    Garibjanian BT; Johnson RK; Kline I; Vadlamudi S; Gang M; Venditti JM; Goldin A
    Cancer Treat Rep; 1976 Sep; 60(9):1347-61. PubMed ID: 797450
    [TBL] [Abstract][Full Text] [Related]  

  • 73. [Studies on the mechanism of antitumor activity of 5-FU and its derivatives--relationship between the inhibition of tumor growth and the inhibition of thymidylate synthetase in vivo].
    Nakamura H; Yu-Qin W; Miyauchi S; Nishioka N; Tanaka H; Harada N; Shirasaka T; Fujii S
    Gan To Kagaku Ryoho; 1984 May; 11(5):1049-55. PubMed ID: 6426401
    [TBL] [Abstract][Full Text] [Related]  

  • 74. From a classic approach in cancer chemotherapy towards differentiation therapy: acyclic and cyclic seven-membered 5-fluorouracil O,N-acetals.
    Campos J; Domínguez JF; Gallo MA; Espinosa A
    Curr Pharm Des; 2000 Dec; 6(18):1797-810. PubMed ID: 11102563
    [TBL] [Abstract][Full Text] [Related]  

  • 75. [Effect of cepharanthine on antitumor activity of 1-(2-tetrahydrofuryl)-5-fluorouracil (FT-207)--5-fluorouracil delivery into tumor tissue].
    Ono M
    Nihon Gan Chiryo Gakkai Shi; 1989 Jul; 24(7):1379-92. PubMed ID: 2509603
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Potentiation of the antitumor activity of tegafur in sarcoma 180-bearing mice by chlordiazepoxide, diazepam and oxazepam.
    Sasaki K; Furusawa S; Monma K; Takayanagi G
    Chem Pharm Bull (Tokyo); 1983 Jul; 31(7):2451-8. PubMed ID: 6139178
    [No Abstract]   [Full Text] [Related]  

  • 77. [Experimental studies on the enhancing effects of the combined therapy with tegafur and cytochrome C].
    Ishibashi S
    Gan To Kagaku Ryoho; 1983 Sep; 10(9):1987-92. PubMed ID: 6311113
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Synthesis and antitumor activity of a series of ftorafur analogues: the effect of varying electronegativity at the 1'-position.
    Holshouser MH; Shipp AM; Ferguson PW
    J Med Chem; 1985 Feb; 28(2):242-5. PubMed ID: 3918171
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Continuous intravenous administration of 1-(2-tetrahydrofuryl)-5-fluorouracil [FT] by intravenous hyperalimentation (IVH)--stability of FT in IVH solution and tumor levels of 5-fluorouracil (5-FU).
    Moriya Y; Koyama Y; Hojo K; Tsunematsu R
    Jpn J Clin Oncol; 1983 Mar; 13(1):31-5. PubMed ID: 6403740
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Hyperthermia enhances the inhibition of tumor growth by 1-(2-tetrahydrofuryl)-5-fluorouracil/uracil (1:4) in tumors in mice and humans.
    Emi Y; Kohnoe S; Yoshida M; Takahashi I; Maehara Y; Sugimachi K
    Cancer; 1992 Sep; 70(5):1177-82. PubMed ID: 1515994
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.